Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4402047 | 0.99 | TPSAB1 (0.52) | TPSAB1F10 | |
| SCHEMBL7018734 | 0.93 | TPSAB1 (0.46) | TPSAB1F10 | |
| SCHEMBL7027368 | 0.93 | TPSAB1 (0.45) | TPSAB1 | |
| Hydrochloric Acid SCHEMBL4395982 | 0.92 | TPSAB1 (0.44) | TPSAB1 | |
| SCHEMBL7025350 | 0.89 | TPSAB1 (0.42) | TPSAB1F10 | |
| Hydrochloric Acid SCHEMBL4403352 | 0.88 | TPSAB1 (0.42) | TPSAB1F10 | |
| SCHEMBL1381265 | 0.88 | TPSAB1 (0.58) | TPSAB1 | |
| Hydrochloric Acid SCHEMBL4408179 | 0.87 | TPSAB1 (0.57) | TPSAB1 | |
| SCHEMBL1872130 | 0.87 | HPN (0.47) | F10 | |
| Hydrochloric Acid SCHEMBL1867557 | 0.86 | HPN (0.46) | F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| EP-1296972-A1 | ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS | Aventis Pharmaceuticals Inc. (US) | 2003-04-02 | — | — | EP | disclosed |
| WO-2001090101-A1 | ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS | AVENTIS PHARMACEUTICALS INC. (US) | 2001-11-29 | — | — | WO | disclosed |